Status:

COMPLETED

BHS5 - Testing the Effectiveness of the Exercise Plus Program

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Hip Fracture

Eligibility:

FEMALE

65+ years

Phase:

NA

Brief Summary

The major goals of this study are: To implement a self-efficacy based intervention to strengthen efficacy beliefs related to exercise, decrease perceived barriers to exercise, and increase exercise b...

Detailed Description

Hip fracture is a major public health problem with striking consequences for the older adult, his or her family, and the health care system. By the year 2040, over 650,00 hip fractures will occur annu...

Eligibility Criteria

Inclusion

  • Hip fracture

Exclusion

  • Male
  • Under 65 years old
  • Non-community dwelling
  • Fractured more than 72 hours before admission to the hospital
  • Pathologic fracture
  • Resides more than 70 from the hospital of admission
  • Recent diagnosis (in past 6 months) of angina or myocardial infarction
  • Myocardial infarction or stroke concurrent with hip fracture
  • Diagnosis of ventricular arrhythmia, third degree heart block, atrial fibrillation or if vital signs=heart \<60 or \>100
  • Active or suspected myocarditis or pericarditis in the past year
  • Recent (within past 6 months) deep venous thrombosis or intracardiac thrombi
  • Persistent pulmonary edema during hospitalization
  • Poorly controlled blood pressure w/ resting systolic \>180 mm Hg or resting diastolic \>100 mm Hg (3 or more readings with 24-hour period)
  • Presence of ventricular aneurysm
  • Paget's Disease
  • Diabetes with blood sugar consistently \> 300
  • Diagnosis of thyrotoxicosis or myxedema within past year
  • Any diagnosis of hyperparathyroidism, hypoparathyroidism, or osteomalacia
  • Parkinson's, multiple sclerosis, or ALS (Lou Gehrig's disease)
  • New (past 6 months) onset seizure disorder or seizure within the past 6 months
  • Diagnosis of schizophrenia
  • Recent (within past 6 months) GI hemorrhage or bleeding
  • Preadmission coumadin therapy
  • Cirrhosis or end stage renal disease (ESRD)
  • Advanced hepatitis, AIDS, or endocarditis
  • Cancer with metastases, or cancer under active treatment (chemotherapy with cytotoxic agents) other than non-melanomic skin cancers
  • Current diagnosis of chronic alcohol abuse
  • Preadmission narcotic use or preadmission benzodiazepine use more than 1 dose or tablet a day
  • Required human assistance to walk prior to fracture
  • Chest pains when climbing a flight of stairs, while walking on level ground, or at rest prior to the hip fracture
  • Use of supplemental oxygen prior to fracture
  • Other (Non-English speaking, severe blindness, paraplegia, hemiplegia
  • Mini-Mental Status Exam score \<20

Key Trial Info

Start Date :

July 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2005

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT00389844

Start Date

July 1 2000

End Date

September 1 2005

Last Update

March 22 2022

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Greater Baltimore Medical Center (GBMC)

Baltimore, Maryland, United States, 21204

2

Harbor Hospital Center

Baltimore, Maryland, United States, 21225

3

St. Agnes Hospital

Baltimore, Maryland, United States, 21229

4

Franklin Square Hospital

Baltimore, Maryland, United States, 21237